Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.90−0.03 (-1.55%)
Close on Nov 17, 2026Market cap $18.96MP/E –Yield –
Atossa Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Atossa Therapeutics's price to book ratio was 0.8× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.5× to 2.5×, with a median of 1.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | −0.8 |
| 2025 | Dec 31, 2025 | 1.5× | −0.1 |
| 2024 | Dec 31, 2024 | 1.6× | +0.5 |
| 2023 | Dec 29, 2023 | 1.1× | +0.6 |
| 2022 | Dec 30, 2022 | 0.5× | −0.9 |
| 2021 | Dec 31, 2021 | 1.4× | +0.4 |
| 2020 | Dec 31, 2020 | 1.0× | +0.1 |
| 2019 | Dec 31, 2019 | 1.0× | +0.4 |
| 2018 | Dec 31, 2018 | 0.5× | −0.9 |
| 2017 | Dec 29, 2017 | 1.4× | +0.4 |
| 2016 | Dec 30, 2016 | 1.0× | −0.1 |
| 2015 | Dec 31, 2015 | 1.1× | −1.2 |
| 2014 | Dec 31, 2014 | 2.3× | −1.2 |
| 2013 | Dec 31, 2013 | 3.5× | −10.4 |
| 2012 | Dec 31, 2012 | 13.9× | – |
See a number that looks wrong?